Stengone Carmine N.

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Stengone Carmine N.'s trades of Contineum Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
191.93
Quantity 25,878
Value US$1,129,145
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-08 2026-09-08
PlS Planned sale
95,446 +26.3%
397.41
US$4,391,543 		95,446 +26.3% 397.41 US$4,391,543
2026-09-08 2026-09-08
PrS Proposed sale
25,878
191.93
US$1,129,145 		25,878 191.93 US$1,129,145
2026-08-03 2026-08-03
PlS Planned sale
48,324 +17.7%
31.10
US$2,582,875 		48,324 +17.7% 31.10 US$2,582,875
2026-08-03 2026-08-03
PrS Proposed sale
2,500
15.49
US$38,725 		2,500 15.49 US$38,725
2026-07-08 2026-07-08
PlS Planned sale
2,500 -12.7%
16.00
US$40,000 		2,500 -12.7% 16.00 US$40,000
2026-07-08 2026-07-08
PrS Proposed sale
2,500
14.56
US$36,400 		2,500 14.56 US$36,400
2026-07-01 2026-06-30
PlS Planned sale
10,000 -36.7%
16.01
US$160,080 		10,000 -36.7% 16.01 US$160,080
2026-06-30 2026-06-30
PrS Proposed sale
10,000
15.00
US$150,000 		10,000 15.00 US$150,000
2026-02-26 2026-02-25
PlS Planned sale
2,700 -15.3%
16.02
US$43,242 		2,700 -15.3% 16.02 US$43,242
2026-02-26 2026-02-24
PlS Planned sale
4,400 -22.7%
16.02
US$70,486 		4,400 -22.7% 16.02 US$70,486
2026-02-13 2026-02-11
PlS Planned sale
400 -2.6%
16.00
US$6,400 		400 -2.6% 16.00 US$6,400
2026-02-11 2026-02-11
PrS Proposed sale
7,500
15.75
US$118,125 		7,500 15.75 US$118,125
2024-09-12 2024-09-11
B Purchase
1,250 +inf%
3.68
US$4,600 		1,250 +inf% 3.68 US$4,600